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Abstract
The concept of overdiagnosis is a dominant topic in medical literature and discussions. In research that 
targets overdiagnosis, medicalisation is often presented as the societal and individual burden of unnecessary 
medical expansion. In this way, the focus lies on the influence of medicine on society, neglecting the possible 
influence of society on medicine. In this perspective, we aim to provide a novel insight into the influence of 
society and the societal context on medicine, in particularly with regard to medicalisation and overdiagnosis.
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Introduction 
The concepts of overdiagnosis and medicalisation are 
related, but not the same.1 Overdiagnosis can be defined 
as: “[t]he detection of abnormalities that are not destined 
to ever bother us” or “that will never cause symptoms or 
death.”2 By medicalisation we mean: “defining a problem 
in medical terms, usually as an illness or disorder, or using 
a medical intervention to treat it.”3 Medicalisation is not by 
definition a negative development, medicalising certain 
situations has had tremendous benefits.4 This in contrast 
to overdiagnosis, in which the ‘over’ inherently indicates 
excess.5 Both overdiagnosis and medicalisation result in more 
people receiving a medical diagnosis. However, the origin of 
this expansion differs. Medicalisation often concerns new 
diagnoses, based on a widened understanding of human 
situations that usually benefit from medical involvement. 
It, thus, widens the boundaries of medicine. Overdiagnosis, 
instead, starts inside of medicine, addressing the problem of 
people receiving a unbeneficial diagnosis.1,6 Both processes 
do not just happen. Medicalisation is created by a specific 
set of cultural and social conditions, and can be pushed by 
forces in and outside of medicine.3,7 Overdiagnosis can also be 
influenced by cultural and societal conditions, yet the current 
discussion focuses primarily on forces inside medicine. In 
recent years, both concepts are becoming more alike, and 
differences are not always clear.1 
However, how the process of medicalisation takes place 
is not resolved with these definitions, nor is the possible 
influence of society on medicine, medicalisation, and 
overdiagnosis addressed. In this perspective, we illustrate 
how societal developments can result in both medicalisation 
and overdiagnosis. We need to bear in mind that society often 
has a interest in more medicine for its inhabitants, to help its 
inhabitants but also to depoliticise social problems.8 This will 
help us get a better grasp on ‘how medicalisation influences 
medicine and overdiagnosis.’
Medicalisation as a Sociological Concept 
Research after overdiagnosis often frames medicalisation 
as the result of forcing unnecessary medicine into people’s 
lives. Although this fits remarkably well with Ivan Illich’ 
well-known view on medicalisation and iatrogenic harms –
introduced in his ground-breaking Medical Nemesis from the 
1970s9 – it also pushes the discussion towards ‘what medicine 
does to people.’ This can easily result in a view of patients as 
the passive recipients of medicine’s well-meant mission creep. 
By doing so we lose track of how medicalisation in its turn is 
also changing - in fact shaping - modern medicine. 
While the historic perspective on medicalisation blamed 
medical imperialism for clinical, social, and cultural 
iatrogenisis,9 contemporary analysts emphasize that 
medicalisation is context dependent, involving actors such 
as the pharmaceutical industry, the media, consumers and/
or, biotechnology.3 Doctors are not necessarily amongst the 
drivers of this process and sometimes fundamentally act as 
gatekeepers. 
Nonetheless, research often focuses on one dominant 
cause, like that after disease mongering blaming the 
pharmaceutical industry for selling sickness and pushing 
medicalisation.10 Sociology has a broader perspective and 
approaches medicalisation as a social process, influenced 
by many actors.3 Society’s norms and values develop at a 
continual pace, influencing all of us in our perception of 
health, what constitutes a medical problem, and who should 
be consulted when experiencing a problem that can be 
perceived as medical.10-12 As a result the definition of health 
and illness develops. Therefore, medicalisation should rather 
be regarded as a continuum than as a dichotomy, as problems 
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can be regarded more or less as medical and can be treated 
more and less intensive. This is an addition to traditional 
definitions of medicalisation, which disregard the extent to 
which a situation or condition is medicalised. 
Societal Implications of Overdiagnosis 
When discussing overdiagnosis and its consequences the 
underlying assumption seems to be that diagnosing is an 
objective and strictly medical procedure, which physicians 
would accomplish beautifully if they would only have the 
perfect knowledge. Besides the conceptual omissions in this 
interpretation of overdiagnosis,13 it is also untrue: disease 
and illness are not merely given biological facts but social 
constructions as well.14,15 The discussion whether disease can 
be defined entire value-free or is unavoidably value-laden 
remains unsettled, although all agree that values do have 
a role in the perception of disease.16 Societal actors such as 
governmental agencies can press their values on the health 
system by policy-making or prioritising certain diseases or 
treatments. 
An example of how ‘disease’ is more complex than a biological 
fact is the current scare for and treatment of hypertension. 
Firstly, this condition is in itself nothing more than a diagnosis 
based on a cut-off point. In the end, this diagnosis solely 
serves to identify a risk factor for cardiovascular conditions, 
such as heart attack and stroke.10,17 Secondly, in the focus on 
lowering this risk with pharmaceutical treatment we may 
overlook that hypertension is one of several risk factors, 
and, even more important, can be lowered or prevented 
with lifestyle change.18 By looking at hypertension from a 
purely medical view, other risk factors such as an unhealthy 
diet, obesity, and physical inactivity are easily overlooked. 
Furthermore, these risk factors are strongly related to socio-
economic determinants such as education and occupation, 
with the result that those that lose out economically are also 
losing out healthwise. Focussing on pharmaceutical quick-
fixes instead of addressing the underlying socio-economic 
problems possibly leads to more inequality, both globally19 
and nationally. As Conrad and Barker put it: “it seems that 
we have a social predilection toward treating human problems 
as individual or clinical – whether it is obesity, substance 
abuse, learning difficulties, aging, or alcoholism- rather than 
addressing the underlying causes for complex social problems 
and human suffering.”15 This does not mean that medicalising 
a situation rules out simultaneous action on its social and 
political determinants. Physicians can be amongst the most 
passionate proponents of societal change for some of the 
medical problems they face in their practices, such as stricter 
regulations for tobacco industry, sugar-taxes on beverages and 
calls for obesity prevention.20-22 Nonetheless, by our tendency 
to seek medical solutions for social problems, we medicalise 
social issues such as inequality, deviance and abnormality and 
locate the sources and solution of these problems increasingly 
on the individual level.15 
Medical Solutions for Societal Questions: Three Examples 
In the previous paragraphs, we have shown that medicalisation 
is more than the result of objective choices made within 
medicine. Here we illustrate this with three examples in which 
societal influences affect the use of medical resources: the care 
for mentally disabled, the increased attention for treatment 
of Alzheimer disease (AD) and mild cognitive impairment 
(MCI) for the elderly, and the medicalisation of childbirth. 
We chose these three examples to illustrate how societal 
developments and medicine can interact. Comparable 
developments are detectable in all areas of healthcare. We 
choose examples that differ with regard to the influence of 
medicalisation and overdiagnosis. We did so to illustrate 
that although they are often related; they are not mutually 
dependent and can occur separately. 
Mental disability can prevent people from full participation 
in society. Those with severe mental disability often have the 
mental abilities of a young child and cannot live unassisted. 
Mentally retarded people are able to function more 
independently but often require assistance in various living 
areas. The number of mentally disabled has not increased 
over the last decade in the Netherlands and the division of 
those with severe mental disability (IQ score below 50), 
moderate mental disability (IQ scores between 50 and 70) and 
those deemed mentally retarded (IQ scores between 70 and 
85) was stable over this period.23 Overdiagnosis seems not 
to be present in this case. Nonetheless, the costs for care and 
assistance for people with mental disabilities has increased 
with 7.3% annually, in the period 2007-2011.24 The increase 
in costs can only partly be ascribed to increases in wages 
and is for the larger part the result of increasing demand 
among people with moderate mental disability or mental 
retardation.24 The number of beds for inpatient care did 
increased with 3.4% annually during this same period.25 Recent 
policy adjustments are aimed at interrupting this trend, but 
effects are not observable yet. What is happening here? The 
threshold for receiving institutional care has lowered towards 
higher IQ scores.23 What does this imply? Can the mentally 
impaired not hold pace with the increasing complexities of 
modern society? Is this supply-induced demand, resulting 
from provider interest? Do we lose our ‘patience’ with slow 
adaptors? Or is more institutional care the medicalised 
answer of a society that ultimately values economic efficiency 
over inclusiveness? The lowering of indication thresholds is 
probably not solely driven by medical professionals but by 
societal demand as well. 
The second example shows that the impact of medicalisation 
may differ as a result of local cultural context. Due to the aging 
populations of most western countries the number of people 
that will receive the diagnoses AD and MCI is increasing. At 
the same time, AD and especially MCI are not uncontested as 
they might medicalise normal aging. A striking illustration is 
the discussion in the United Kingdom about early detection 
of AD. Governmental policy stimulates doctors and practices 
to increase their number of dementia diagnoses, to benefit 
patients with earlier diagnosis and better treatmen.26 Doctors 
disagreed, stating that earlier diagnosis has no proven benefit, 
MCI does not necessarily result in dementia and overdiagnosis 
looms.27,28 This is an example of doctors acting as gatekeepers 
to prevent further medicalisation and overdiagnosis. 
Furthermore, what distinguishes MCI or even AD from 
‘normal’ cognitive aging is still unclear after a century of 
research.29 This further emphasizes how disease thresholds 
and diseases are socially constructed.30 More poignant 
is how cultural norms and contextual factors influence 
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how medicalisation takes place. The Dartmouth atlas 
shows the percentage of people over 65 filling at least one 
prescription of dementia medication in 2010 in the United 
States. Percentages differ between regions, ranging from 3.7 
to 17.1%[1]. This reveals large practice variation within the 
United States. Striking as this is, the figure conceals how 
high a percentage as low as 3.7% might be from another 
cultural perspective. In the Netherlands, 1.2% of people over 
65 used dementia medication at least once in 2013[2]. The 
prevalence of dementia is slightly higher in the Netherlands 
than in the United States.31 Overdiagnosis does not seem to 
be present here, but over- or undertreatment may be at stake.5 
This cannot be determined here. What we do know is that 
people with advanced AD more often receive long term care 
in the Netherlands than they do in the United States.32 It is 
not obvious whether use of pharmaceuticals or intuitional 
care constitutes of more medicalisation as both use medical 
language, medical assistance and a share of the healthcare 
budget. A highly relevant but understudied research question 
is how overdiagnosis and medicalisation drive different 
treatment options across different countries and communities. 
Childbirth is one of the examples where medicalisation has 
had significant benefits, diminishing the chances of maternal 
and child mortality. Access to medical care in case of 
complications during pregnancy or birth is essential. However, 
there is an ongoing debate whether nowadays the standard 
care for pregnancy in most western countries involves 
too much medicine and is beyond the point of provable 
benefit.33 Childbirth is an example of how medicalisation 
can be regarded as a continuum: Less medicalised assistance 
in pregnancy and birth, as provided by a midwife, differs in 
intensity of medical intervention from gynaecological and 
surgical interventions. Midwife assisted birth can, thus, be 
considered a less medicalised situation. 
A well-established example of increasing medicalisation for 
childbirth is caesarean section rates (CSR). It is known that CSR 
vary greatly between countries and that these rates increased 
in the last decennia in many countries.34 The World Health 
Organization (WHO) regards a CSR between 10% and 15% 
ideal and states that no reduction in maternal and newborn 
mortality outcomes at the population level are found at a CSR 
higher than 15%.35 Higher percentages, at least on group level, 
could thus, be interpreted as an indication of overdiagnosis. 
Most western countries exceed this percentage, which ranged 
in Europe from 14.8% in Iceland to 52.2% in Cyprus in 2010.36 
In the United States, 31.8% of live births was delivered by CSR 
in 2007.34 The choice for CSR depends on many variables on 
the individual and health system level.37,38 The percentage of 
women preferring CS varies between countries, but never 
exceed 14%.39 In the Netherlands, the CSR is 17.0%, the 
third lowest level in Europe.36 Nonetheless, the percentage of 
homebirths is decreasing, while the use of epidurals increases 
and the CSR rises, indicating that childbirth is in the process 
of being further medicalised in the Netherlands as well.40 
This example illustrates that many factors can contribute to 
medicalisation, on several levels. 
The Dual Relationship Between Overdiagnosis and Medicalisation 
The three examples illustrate that the societal context 
influences medical decision-making as well. We illustrated 
Figure. Coleman’s Boat.41
how medicalisation can occur on its own regard and 
how it can lead to overdiagnosis. Coleman’s boat shaped 
scheme provides a nice metaphor to illustrate this (Figure). 
Crucial to this metaphor is the relation between macro and 
micro developments. Consider medicalisation as a macro 
condition: a set of societal norms and values, influencing 
us all. This influences behaviour and expectations on the 
micro level, in the consultation between doctor and patient, 
allegedly resulting in more diagnoses and treatments. As a 
macro result, an increasing use of healthcare and possibly 
overdiagnosis is detected. For example: within a more 
medicalised society, acceptance of forgetfulness amongst 
the elderly decreases. As a result elderly people grow more 
conscious of their forgetfulness and consult their physicians 
more often and probably earlier than they would have done 
otherwise, resulting in an increasing number of diagnoses 
and prescriptions. 
The metaphor stops here, but we suggest adding another 
relation. An extra dotted arrow should be drawn from macro 
result to macro condition, indicating that a macro result in turn 
also influences the macro condition. In this case, overdiagnosis 
further enhances medicalisation. The suspected mechanism 
behind this lies in the increasing societal consciousness of 
conditions and its treatments, decreasing the individual and 
societal tolerance to endure everyday complaints. 
To Conclude
In this perspective, we argue that instead of solely a result 
of medicine, medicalisation and overdiagnosis consists of 
social cultural processes that take place both in and outside 
medicine. Medicalisation entails a complex set of drivers, 
including interests, existing institutional rules, and the way 
society defines ‘disease’ and ‘normality.’ Both overdiagnosis 
and medicalisation push healthcare consumption and lead 
to additional healthcare costs. Medicalising a situation can 
improve the health status of new patients. The question 
remains whether the possible benefits are worth the individual 
suffering, iatrogenic damage or social exclusion that can also 
be the result of it. To answer this question, medicalisation and 
overdiagnosis need to be analysed in a broader context, also 
taking into account societal aspects. 
Medicalisation should be perceived as a societal phenomenon; 
as a multiplayer game, involving societal forces, institutional 
rules and stakeholder interests. Medicalisation and 
overdiagnosis hold an ambivalent relationship. Medicalisation 
partly follows from overdiagnosis in the doctor’s office. At 
the same time, due to increasing medicalisation at the macro 
level overdiagnosis on the micro level is induced. Societal 
developments and values, thus, influence the practice of 
medicine. This is a relationship we all should be conscious 
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